PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,0551,60750,854676
Cost of Revenue119,53458,43938,45226,052
Gross Profit-118,479-56,83212,402-25,376
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses151,89081,54457,50341,103
Operating Income or Loss-150,835-79,937-6,649-40,427
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-150,835-79,937-6,649-40,427
Interest Expense----
Income Before Tax----
Income Tax Expense1,144701811415
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-160,108-80,612-7,150-40,996
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----